Whole body hyperthermia reduces oxidative stress in the striatum of rats in an animal model of mitochondrial toxicity with 3-nitropropionic acid

International Journal of Hyperthermia

Volumn 25, Issue 4, 2009, Pages 280-288

  Medina Navarro, Rafael ^a   Guerrero Linares, Israel ^a  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

3 nitropropionic acid; Oxidative stress; Striatum; Thermotolerance; Whole body hyperthermia

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; BIOGENIC AMINE; CARBONYL DERIVATIVE; HEAT SHOCK PROTEIN 72; HYDROXYL RADICAL; NORADRENALIN; SALICYLIC ACID; 3-NITROPROPIONIC ACID; DOPAMINE; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; HYDROXYLATION; HYPERTHERMIA; MALE; METABOLIC DISORDER; MITOCHONDRIAL TOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; TEMPERATURE STRESS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HEAT SHOCK RESPONSE; HYPERTHERMIC THERAPY; METABOLISM; MITOCHONDRION; MOTOR ACTIVITY; PROTEIN CARBONYLATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; HEAT-SHOCK RESPONSE; HSP72 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; MALE; MITOCHONDRIA; MOTOR ACTIVITY; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; PROTEIN CARBONYLATION; RATS; SUCCINATE DEHYDROGENASE;

EID: 70349896185     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730902744387     Document Type: Article

References (38)

1. Wang JL, Ke DS, Lin MT. Heat shock pretreatment may protect against heatstroke-induced circulatory shock and cerebral ischemia by reducing oxidative stress and energy depletion. Shock 2005;23(2):161-167.
2. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867.
3. Lee WC, Wen HC, Chang CP, Chen MY, Lin MT. Heat shock protein 72 overexpression protects against hyperthermia, circulatory shock, and cerebral ischemia during heatstroke. J Appl Physiol 2006;100:2073-2082.
4. Field SB, Anderson RL. Thermotolerance: A review of observations and possible mechanisms. Natl Cancer Inst Monogr 1982;61:193-201.
5. Yang YL, Lin MT. Heat shock protein expression protects against cerebral ischemia and monoamine overload in rat heatstroke. Am J Physiol 1999;276:H1961-H1967.
6. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-1623.
7. Knight JA. Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci 1997;27:11-25.
8. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 2001;7:548-554.
9. Alston TA, Mela L, Bright HJ. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci USA 1977;74: 3767-3771.
10. Coles CJ, Edmondson DE, Singer TP. Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 1979;254:5161-5167.
11. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451:205-212.
12. Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind R, Borrelli E, Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 2001;21:5110-5120.
13. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-4192.
14. Wullner U, Young AB, Penney JB, Beal MF. 3-Nitropropionic acid toxicity in the striatum. J Neurochem 1994;63:1772-1781.
15. Hamilton BF, Gould DH. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage. Acta Neuropathol 1987;72:286-297.
16. Binienda Z, Simmons C, Hussain S, Slikker Jr W, Ali SF. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain. Neurosci Lett 1998;251:173-176.
17. Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF. Agedependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 1993;60:356-359.
18. Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz J. B.3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J Neurochem 1995;65:919-922.
19. Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 1995;15: 8419-8429.
20. Maragos WF, Jakel RJ, Pang Z, Geddes JW. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Exp Neurol 1998;154:637-644.
21. Bowyer JF, Clausing P, Schmued L, Davies DL, Binienda Z, Newport GD, Scallet AC, Slikker Jr W. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum. Brain Res 1996;712:221-229.
22. Ahuja M, Bishnoi M, Chopra K. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 2008;244:111-122.
23. Reznick AZ, Packer L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-363.
24. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32:790-796.
25. Halliwell B, Grootveld M, Gutteridge JM. Methods for the measurement of hydroxyl radicals in biomedical systems: Deoxyribose degradation and aromatic hydroxylation. Methods Biochem Anal 1988;33:59-90.
26. Ghiselli A, Laurenti O, De Mattia G, Maiani G, Ferro-Luzzi A. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radic Biol Med 1992;13:621-626.
27. Loullis CC, Felten DL, Shea PA. HPLC determination of biogenic amines in discrete brain areas in food deprived rats. Pharmacol Biochem Behav 1979;11:89-93.
28. Ase AR, Reader TA, Hen R, Riad M, Descarries L. Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice. J Neurochem 2000;75:2415-2426.
29. Belay HT, Brown IR. Spatial analysis of cell death and Hsp70 induction in brain, thymus, and bone marrow of the hyperthermic rat. Cell Stress Chaperones 2003;8: 395-404.
30. Cheng N, Maeda T, Kume T, Kaneko S, Kochiyama H, Akaike A, Goshima Y, Misu Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res 1996;743:278-283.
31. Hattori A, Luo Y, Umegaki H, Munoz J, Roth GS. Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats. Neuroreport 1998;9:2569-2572.
32. Reynolds DS, Carter RJ, Morton AJ. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 1998;18:10116-10127.
33. Johnson JR, Robinson BL, Ali SF, Binienda Z. Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats. Toxicol Lett 2000;116:113-118.
34. Burke WJ. 3,4-dihydroxyphenylacetaldehyde: A potential target for neuroprotective therapy in Parkinson's disease. Curr Drug Targets CNS Neurol Disord 2003;2:143-148.
35. Wallace LJ. A small dopamine permeability of storage vesicle membranes and end product inhibition of tyrosine hydroxylase are sufficient to explain changes occurring in dopamine synthesis and storage after inhibition of neuron firing. Synapse 2007;61:715-723.
36. Burke WJ, Li SW, Williams EA, Nonneman R, Zahm DS. 3,4- Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: Implications for Parkinson's disease pathogenesis. Brain Res 2003;989:205-213.
37. Lord-Fontaine S, Averill-bates D. Heat shock inactivates cellular antioxidant defenses against hydrogen peroxide: Protection by glucose. Free Radic Biol 2002;32:752-765.
38. Gao JP, Friedman S, Lanks KW. The role of reduced nicotinamide adenine dinucleotide phosphate in glucose and temperature-dependent doxorubicin cytotoxicity. Cancer Chemother Pharmacol 1993;33:191-196.